Hematology studies the blood and its main components (red blood cells, white blood cells, platelets, plasma). The complete blood count is essential for assessing eligibility to donate blood.

In fact, the pre-donation complete blood count is crucial:

• It protects the donor from risks associated with donation (anemia, depletion of blood reserves).
• It safeguards the recipient by ensuring quality blood, free from hematological contamination.
• It makes the donation process a useful moment for monitoring one’s own health.
• In the field of oncohematology, particular attention is given to acute myeloid leukemia (AML), a condition characterized by specific genetic alterations. The identification of chromosomal translocations and gene mutations allows for the classification of disease subtypes, defining the prognostic profile, and guiding therapeutic choices based on individual risk.

The molecular solutions offered by Astra Formedic enable the simultaneous detection of the main aberrations associated with AML, supporting diagnosis, risk stratification, and monitoring of minimal residual disease (MRD), with methods compatible with clinical workflows and high-complexity laboratories.